Caris Life Sciences earnings were N/A for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CAI earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$127.0M, down N/A from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CAI reported annual earnings of -$378.3M, with -18.2% growth.
Caris Life Sciences Earnings Reports & History FAQ
What were Caris Life Sciences's earnings last quarter?
Caris Life Sciences (NASDAQ: CAI) reported Q1 2025 earnings per share (EPS) of -$3.57, up 6.05% year over year. Total CAI earnings for the quarter were -$127.04 million. In the same quarter last year, Caris Life Sciences's earnings per share (EPS) was -$3.80.
Is Caris Life Sciences profitable or losing money?
As of the last Caris Life Sciences earnings report, Caris Life Sciences is currently losing money. Caris Life Sciences's net profit (also called net income) for the twelve months ending Mar 31, 2025 was N/A, a N/A decrease year over year.
What was CAI's earnings growth in the past year?
As of Caris Life Sciences's earnings date in Q2 2025, Caris Life Sciences's earnings has grown year over year. CAI earnings in the past year totalled N/A.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.